Skip to main content

Table 3 Docking scores and receptors amino acids involved in the interactions with the ligand compounds

From: Comprehensive chemical profiling of Bassia indica Wight. aerial parts extract using UPLC-ESI–MS/MS, and its antiparasitic activity in Trichinella spiralis infected mice: in silico supported in vivo study

Ligands

1OJ0

3D Ts-CrT_3RG0

3D Ts-CF1_1M6D

2AZ5

∆G*

Receptor Amino Acids Involved in Interactions and Distance (Å)

∆G*

Receptor Amino Acids Involved in Interactions and Distance (Å)

∆G*

Receptor Amino Acids Involved in Interactions and Distance (Å)

∆G*

Receptor Amino Acids Involved in Interactions and Distance (Å)

ABZ

-7.67

Val236 (3.38), Ser165 (2.84), Gln134 (3.27)

-5.01

Glu201a (3.21), His302c (3.59)

-5.22

Gly168a (3.05), Trp335c (3.55)

-5.74

Tyr119c (4.33)

1

58.53

Glu198a (3.01), Val236a (2.78), Leu250b (2.87)

-6.42

Thr207a (2.93), Glu201a (2.97)

Arg162b (3.11 & 3.05)

-7.00

Cys173a (3.56), Asp166a (3.49 & 2.97)

-7.61

Tyr151b (3.07)

2

84.79

Ser165a, b (2.52 & 3.06), Asn226b (3.42), Cys12b (3.23)

-7.23

Asp202a (2.78), Arg199b (2.98)

-7.32

Asp166a (2.90 & 2.81), Cys173a (3.38), Asn308a (3.45 & 3.03), Trp335c (4.35)

-9.70

Tyr119c (3.60)

3

85.16

Val226a (2.50), Ser165b (3.14), Asn226b (2.82), Phe200c (3.70)

-6.88

Glu201a (3.30), Asp202a (2.82 & 3.47), Arg199b (3.20)

Lys163b (3.10)

-7.79

Asn308a (3.35), Cys173a (3.21)

Asp166a (2.90 & 2.95 & 3.05)

-8.43

Leu120a (2.92), Tyr151b (2.79)

4

66.66

Asn204a (3.08), Asn226a (3.09), Glu198a (2.73), Ser165b (2.84), Gln134b (2.61)

-7.96

Glu201a (3.46), Arg199b (3.12)

-7.82

Asn308a (3.13), Cys173a (3.04)

Trp335a (3.42), Asp166a (2.89)

-9.10

Tyr151b (2.99), Tyr59c (4.25)

5

102.98

Glu198a (2.82 & 3.29), Val236a (3.35), Ser165a,b (2.87 & 2.53), Tyr222b (2.79)

-7.69

Asp202a (3.55), Ser185a (3.14)

Asn183b (3.39)

-8.34

Asn308a (3.18), Glu212a (2.98)

Cys173a (4.06), Asp166a (3.00)

Trp174b (3.32), Trp335c (4.30 & 3.99)

-9.97

Tyr151b (2.72)

6

51.58

Met233a (3.36), Gln134b (2.50), Tyr50b (2.93), His28b (3.26)

-6.74

-7.50

Cys173a (3.16), Gly214b (3.07)

-8.21

Tyr119b (2.90)

7

78.49

Glu198a (2.56 & 2.61), Met233a (2.68), Gln134b (2.61)

-6.85

Lys157b (3.10)

-7.34

Asn308a (3.09), His309a (3.44)

Cys173a (3.68)

-7.94

Tyr151b (3.02)

8

134.90

Met233a (3.81), Ile202a (3.30), Thr237a (3.23), Glu198a (2.40 & 2.37), Val236a (3.03), Ser165b (2.52), Leu250b (2.82)

-7.18

Asp202a (3.48), Glu187a (3.17)

Glu201a (2.85), Arg199b (3.13)

Leu210b (3.35)

-7.87

His309a (3.13)

-9.64

Gly121a (2.95), Tyr151b (2.93)

Tyr59c (4.48)

9

79.28

Ser168a (3.15), Thr237a (2.38), Phe20c (4.11)

-6.68

Asp202a (3.12 & 2.96)

-6.81

Cys173a (3.49), Trp335c (4.09 & 4.53)

-8.21

10

72.24

Met233a (3.28), Ser165a (3.19 & 2.39), Gln134b (2.83), Thr237b (2.93)

-7.35

Arg199b (3.13)

-6.85

Ile294a (2.93), His296a (2.92)

-8.83

Tyr59c (4.01)

11

95.55

Phe167a (2.79), Met233a (3.01), Val236a (3.13), Thr237a (2.41), Glu198a (2.64 & 2.45), Asn204a (2.55 & 2.66), Leu250b (3.08), Ser165b (2.56), Phe167c (4.83)

-7.15

Asp202a (3.41 & 2.86)

Glu187a (2.89), Thr207a (2.88)

Arg162b (3.00), Lys194b (3.05)

-8.15

Asn308a (3.32 & 2.79), Cys173a (3.24), Trp335a,c (3.09 & 3.88), Asp166a (2.81)

-9.03

Tyr119a (3.04)

12

73.39

Met233a, b (3.33 & 3.29), Val236a (2.87), Ser165b (2.91), Gln134b (2.67), Thr238b (2.67)

-6.85

Glu201a (2.81), Asp202a (2.90)

-7.51

Asp166a (3.03), Asp166a (3.16)

Trp335c (3.86)

-7.83

Leu157a (2.92), Lys98b (3.10 &

3.18), Lys11b (3.21), Tyr119c (3.96)

13

89.38

Met233a (2.50), Ser165b (2.36 & 2.77), Leu250b (2.97), Thr238b (2.74)

-7.22

Glu201a (2.95)

-8.02

Asn308a (3.23), His309c (4.14)

-8.21

Tyr119a (3.27)

14

0.44

Cys12a (4.01), Met233c (3.93), Phe167d (3.86)

-5.39

Leu210b (3.17)

-6.13

His309a (2.99), Trp335d (3.77)

-6.98

Leu57c (4.27), Tyr119e (3.81)

15

6.07

Val236a (2.93), Glu198a (2.64), Gln134a (2.57), Gln134b (2.57), Thr238b (2.97)

-5.98

Asp202a (3.47), Arg162b (3.38)

-6.69

Asn169a (2.92), Asp166a (3.20)

Cys173a (3.37), Gly171c (4.68)

Trp335d (3.88)

-7.77

Tyr59c (4.22)

16

4.57

Glu198a (2.74), Asp249a (2.84), Leu250a (3.21), Ser165b (3.16)

-6.08

Thr207a (2.78), Glu201a (2.95 & 2.90), Leu210b (3.08)

-6.76

Cys173a (3.18), Gly213c (3.80)

-7.58

Tyr119c (4.07)

17

6.16

Val236a (3.14), Glu27a (3.03), Ser165a (3.11), Gln134b (2.80)

-6.07

Asp202a (2.99), His211a (3.00)

Glu201a (2.78), Leu210b (3.02)

Arg162b (2.99), Thr205c (3.82)

-6.93

His309a (3.48), Asp166a (3.31)

Cys173a (3.59), Met288a (3.03)

Gln167b (2.98)

-7.90

18

33.67

Ser230a (3.19), Glu198a (2.51), Val236a (2.99), Gln134b (2.44 & 2.63), Ser165b (2.95)

-7.00

Asp202a (2.90), Thr207a (2.95)

His211b (2.97 & 3.54)

-7.59

Asn169a (3.11), Cys173a (3.14)

Asp166a (2.88), Asn169a (3.00)

Trp335c, d (4.57 & 3.80)

-8.53

Tyr119a, c (2.94 & 4.69), Leu157a (2.80), Lys11b (3.04),

Tyr59c (4.45)

19

58.36

Met233a (3.51), Phe167a (2.44), Thr237a (2.38), Glu27a (2.98), Gln134b (2.78), Ser165b (2.90)

-7.46

Asp202a (3.40), Glu201a (3.01)

His302a (3.12), Arg162b (3.09)

Arg199b (2.97), Pro209c (4.61)

Leu210c (4.67)

-7.75

Asp166a (3.43), Cys173a (3.60)

Glu212a (2.85), Gln167b (2.97)

His309c (3.99), Asn308c (4.59)

Trp335c (3.95)

-8.47

Tyr151b (3.21)

  1. * (Kcal/mol), a H-donor, b H-acceptor, c H-Pi, d Pi-Pi, e Pi-cation
  2. Bold: Key amino acid residues, Bold and italic: Key amino acid residues associated with resistance mutation